ACAD:NASDAQ
ACADIA Pharmaceuticals Inc
$19.65
arrow_downward
-0.46%(-0.090) 1D
$19.80
arrow_upward
+0.75% (+0.15)todayPre-market
Closed: Oct 7, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ACAD...
Open
$19.60
High
$19.80
Low
$19.46
Mkt. cap
3.39B
Avg. vol.
2.05M
Volume
0.00
P/E ratio
8.88
52-wk high
$30.96
52-wk low
$19.46
EPS
$2.21
Beta
0.89
Shares outstanding
172.31M
No. of employees
797
Open
$19.60
High
$19.80
Low
$19.46
Mkt. cap
3.39B
Avg. vol.
2.05M
Volume
0.00
P/E ratio
8.88
52-wk high
$30.96
52-wk low
$19.46
EPS
$2.21
Beta
0.89
Shares outstanding
172.31M
No. of employees
797
News stories
From web sources and news partners
Simply Wall Street
·
9 hours ago
What Acadia Pharmaceuticals (ACAD)'s Phase 2 Readout Means For Shareholders
Yahoo Finance
·
12 hours ago
ACADIA Pharmaceuticals Inc. (ACAD) Stock Forecasts
AD HOC NEWS
·
1 day ago
RBC keeps Outperform on ACADIA Pharmaceuticals stock at USD 37
Profile
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California. Wikipedia
About ACADIA Pharmaceuticals Inc
CEOCatherine Owen Adams
Employees797
Founded1993
HeadquartersSan Diego, California, United States
SectorBiotechnology
Websiteacadia.com